Atlas Trials

Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.

Clinical trial NCT04702789 · TERMINATED

Trial details

NCT number
NCT04702789
Sponsor
Laboratorios Sophia S.A de C.V.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Glaucoma, Open-AngleOcular Hypertension
Start date
2021-10-19
Primary completion
2023-11-23
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.